Blueprint Medicines
BPMC
#2437
Rank
A$9.14 B
Marketcap
$143.12
Share price
3.12%
Change (1 day)
5.42%
Change (1 year)

EPS for Blueprint Medicines (BPMC)

EPS in 2023 (TTM): -$13.83

According to Blueprint Medicines 's latest financial reports the company's current EPS (TTM) is -$14.53. In 2022 the company made an earnings per share (EPS) of -$14.79 an increase over its 2021 EPS that were of -$17.36.

EPS history for Blueprint Medicines from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$13.83-6.5%
2022-$14.79-14.85%
2021-$17.36-297.13%
2020$8.81-176.3%
2019-$11.5435.19%
2018-$8.5438.82%
2017-$6.1547.35%
2016-$4.189.25%
2015-$3.82-31.35%
2014-$5.57

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$0.11-99.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.43-97.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.01-86.18%๐Ÿ‡บ๐Ÿ‡ธ USA